immune response inflammatory response
Conditions
Interventions
None listed
Sponsors
Catharina-ziekenhuis
Eligibility
Age
18 Years to 99 Years
Inclusion criteria
Inclusion criteria: - Subjects who undergo elective surgery in which the splenic artery is exposed as part of the procedure - Written informed consent - Older than 18 years
Exclusion criteria
Exclusion criteria: - Previous splenectomy - Use of steroids 4 weeks prior to inclusion - Use of immunosuppresive agents (e.g. methotrexate, biologicals)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Mapping of the systemic inflammatory response, as measured by means of pro-inflammatory cytokines, protein and transcript expression. Cytometric bead array will be used to identify important pro-inflammatory cytokines, amongst which most likely TNF-alpha, interferon gamma and interleukins such as IL-1, IL-6, IL-8, and IL-10. These cytokines will be analyzed in more detail using assays such as Enzyme Linked ImmunoSorbent Assay (ELISA) and by means of Polymerase Chain Reaction (PCR) for transcript expression. | — |
Secondary
| Measure | Time frame |
|---|---|
| - the effect of ex vivo lipopolysaccharide (LPS) stimulations on the Toll-like receptor (TLR) responses of monocytes in these patients. - the effect on the local pro- and anti-inflammatory responses in splenic tissue in patients undergoing pancreaticosplenectomy (RAMPS procedure). - the presence of nerve fibres in the gastrosplenic ligament in patients undergoing pancreaticosplenectomy or esophagectomy. | — |
Countries
Netherlands
Outcome results
None listed